Healthcare Provider and Patient Segmentation Framework

HCP SEGMENTS:

1. Efficacy-Driven Specialists (Endocrinologists, 25%)
- Profile: Academic and community endocrinologists managing complex T2D
- Priorities: Maximum A1C reduction, weight loss, latest therapies
- Mounjaro Fit: "Best-in-class" efficacy for difficult-to-control patients
- Messaging: Superior outcomes data, novel MOA, comprehensive SURPASS results
- Objections: None significantâ€”early adopters excited by differentiation

2. Evidence-Based PCPs (35%)
- Profile: Primary care physicians who stay current on guidelines
- Priorities: Proven efficacy, safety, clear place in therapy
- Mounjaro Fit: Option for patients not at goal on metformin +/- other agents
- Messaging: ADA-recognized therapy, robust phase 3 data, CV safety
- Objections: Cost/coverage concerns, prior auth burden, GI side effects

3. Safety-First Prescribers (30%)
- Profile: Conservative PCPs, older physicians, risk-averse
- Priorities: Established safety, tolerability, avoiding complications
- Mounjaro Fit: Low hypoglycemia risk, manageable GI profile
- Messaging: Favorable safety profile, predictable titration, patient support
- Objections: "Too new," prefer waiting for longer-term data

4. Convenience-Focused Physicians (10%)
- Profile: High-volume PCPs prioritizing simple regimens
- Priorities: Once-weekly dosing, easy titration, patient adherence
- Mounjaro Fit: Simple weekly injection with straightforward titration
- Messaging: Convenient dosing, comprehensive patient support program
- Objections: None if coverage is good

PATIENT ARCHETYPES:

1. The Proactive Manager (30%)
- Demographics: 45-60 years, recently diagnosed or well-controlled
- Psychology: Takes ownership, researches options, wants best outcomes
- Motivations: Prevent complications, maintain independence, optimize health
- Concerns: Disease progression despite current efforts
- Mounjaro Appeal: Superior efficacy data, comprehensive control

2. The Overwhelmed Struggler (35%)
- Demographics: 50-70 years, multiple comorbidities, A1C >8%
- Psychology: Feels defeated by disease progression, medication burden
- Motivations: Simplify treatment, reduce pill burden, see real results
- Concerns: Complexity, cost, side effects, feeling like a "failure"
- Mounjaro Appeal: Powerful results with simple once-weekly dosing

3. The Weight-Focused Patient (20%)
- Demographics: 35-55 years, obesity-driven T2D, image-conscious
- Psychology: Frustrated by weight gain from diabetes meds
- Motivations: Weight loss as much as glucose control, improve appearance
- Concerns: Medications that worsen weight problem
- Mounjaro Appeal: Significant weight loss alongside glucose control

4. The Cost-Conscious Pragmatist (15%)
- Demographics: 55-75 years, fixed income, Medicare/limited coverage
- Psychology: Practical, seeks "good enough" control within budget
- Motivations: Avoid complications without financial strain
- Concerns: Medication costs, insurance coverage, out-of-pocket expenses
- Mounjaro Appeal: Depends entirely on coverage/copay assistance availability